Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 62 | $45,336,231 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Jul 2024 17:30 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jul 2024 | Sale | 2,743 | 62 | 170,066 | I |
17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jul 2024 | Sale | 14,257 | 63.16 | 900,472 | I |
17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Jul 2024 | Sale | 22,000 | 64.27 | 1,413,940 | I |
17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Jul 2024 | Sale | 11,000 | 63.38 | 697,180 | I |
24 Jun 2024 16:12 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 21 Jun 2024 | Sale | 20,000 | 58.9 | 1,178,000 | I |
20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 Jun 2024 | Sale | 11,447 | 59.86 | 685,217 | I |
20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jun 2024 | Sale | 10,607 | 60.76 | 644,481 | I |
20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jun 2024 | Sale | 7,946 | 61.41 | 487,964 | I |
21 May 2024 17:21 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 May 2024 | Sale | 12,855 | 61.81 | 794,568 | I |
17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 May 2024 | Sale | 5,836 | 62.09 | 362,357 | I |
17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 May 2024 | Sale | 16,459 | 63.84 | 1,050,743 | I |
17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 May 2024 | Sale | 14,850 | 65.86 | 978,021 | I |
22 Apr 2024 18:26 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Apr 2024 | Sale | 16,809 | 65.17 | 1,095,443 | I |
22 Apr 2024 18:26 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Apr 2024 | Sale | 10,423 | 64.98 | 677,287 | I |
17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Apr 2024 | Sale | 9,520 | 65.4 | 622,608 | I |
17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Apr 2024 | Sale | 5,834 | 66.2 | 386,211 | I |
17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Apr 2024 | Sale | 7,414 | 66.33 | 491,771 | I |
11 Mar 2024 18:43 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 08 Mar 2024 | Sale | 10,000 | 67.17 | 671,700 | I |
07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 07 Mar 2024 | Sale | 15,085 | 66.35 | 1,000,890 | I |
07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 06 Mar 2024 | Sale | 14,822 | 65.47 | 970,396 | I |
07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 05 Mar 2024 | Sale | 10,093 | 65.35 | 659,578 | I |
23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 23 Jan 2024 | Sale | 15,000 | 56.44 | 846,600 | I |
23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Jan 2024 | Sale | 4,524 | 55.57 | 251,399 | I |
23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 22 Jan 2024 | Sale | 5,692 | 55.95 | 318,467 | I |
18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jan 2024 | Sale | 10,000 | 55.11 | 551,100 | I |
18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jan 2024 | Sale | 9,784 | 55.3 | 541,055 | I |
18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Jan 2024 | Sale | 5,000 | 55.63 | 278,150 | I |
19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Dec 2023 | Sale | 25,000 | 52.65 | 1,316,250 | I |
19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Dec 2023 | Sale | 13,026 | 52.44 | 683,083 | I |
19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Dec 2023 | Sale | 11,974 | 52.44 | 627,917 | I |
20 Nov 2023 21:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Nov 2023 | Sale | 13,000 | 51 | 663,000 | I |
20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Nov 2023 | Sale A | 6,448 | 51.66 | 333,104 | I |
20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Nov 2023 | Sale A | 7,647 | 53.64 | 410,185 | I |
20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Nov 2023 | Sale A | 22,905 | 53.17 | 1,217,859 | I |
16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Nov 2023 | Sale | 6,448 | 51.66 | 333,104 | I |
16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Nov 2023 | Sale | 7,647 | 53.64 | 410,185 | I |
16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Nov 2023 | Sale | 22,095 | 53.17 | 1,174,791 | I |
19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Oct 2023 | Sale | 6,242 | 57.78 | 360,663 | I |
19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Oct 2023 | Sale | 10,000 | 57.06 | 570,600 | I |
19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Oct 2023 | Sale | 8,758 | 58.53 | 512,606 | I |
17 Oct 2023 16:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 13 Oct 2023 | Sale | 11,937 | 57.58 | 687,332 | I |
17 Oct 2023 16:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Oct 2023 | Sale | 13,063 | 58.31 | 761,704 | I |
19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Sep 2023 | Sale | 25,333 | 61.23 | 1,551,140 | I |
19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Sep 2023 | Sale | 8,425 | 61.64 | 519,317 | I |
19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Sep 2023 | Sale | 16,242 | 62.81 | 1,020,160 | I |
30 Aug 2023 16:29 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 29 Aug 2023 | Sale | 25,000 | 63.37 | 1,584,250 | I |
30 Aug 2023 16:29 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 28 Aug 2023 | Sale | 25,000 | 63.06 | 1,576,500 | I |
16 Aug 2023 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Aug 2023 | Sale | 22,110 | 61.6 | 1,361,976 | I |
16 Aug 2023 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Aug 2023 | Sale | 27,890 | 61.15 | 1,705,474 | I |
21 Jul 2023 19:15 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 21 Jul 2023 | Sale | 11,500 | 52.56 | 604,440 | I |
21 Jul 2023 19:15 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 Jul 2023 | Sale | 6,000 | 51.52 | 309,120 | I |
21 Jul 2023 19:15 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Jul 2023 | Sale | 5,969 | 51.48 | 307,284 | I |
18 Jul 2023 20:06 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jul 2023 | Sale | 6,700 | 51.84 | 347,328 | I |
18 Jul 2023 20:06 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jul 2023 | Sale | 9,831 | 51.06 | 501,971 | I |
18 Jul 2023 20:06 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Jul 2023 | Sale | 10,000 | 50.43 | 504,300 | I |
23 Jun 2023 20:01 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 23 Jun 2023 | Sale A | 10,000 | 51.49 | 514,900 | I |
23 Jun 2023 20:01 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 22 Jun 2023 | Sale A | 13,500 | 51.38 | 693,630 | I |
23 Jun 2023 20:01 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 21 Jun 2023 | Sale A | 11,843 | 51.95 | 615,244 | I |
23 Jun 2023 20:01 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 Jun 2023 | Sale A | 14,657 | 51.93 | 761,138 | I |
22 Jun 2023 20:00 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 22 Jun 2023 | Sale | 13,500 | 51.38 | 693,630 | D |
22 Jun 2023 20:00 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 21 Jun 2023 | Sale | 11,843 | 51.95 | 615,244 | D |
22 Jun 2023 20:00 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 Jun 2023 | Sale | 14,657 | 51.93 | 761,138 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)